2023/12 - Final CAD(K$) | %Chg (Compare to Final) | 2022/12 CAD(K$) | 2021/12 CAD(K$) | 2020/12 CAD(K$) | 2019/12 CAD(K$) | |
Insurance Revenue | 23,972,000 | 3.694% | 23,118,000 | -- | -- | -- |
Interest Income | 12,802,000 | 6.126% | 12,063,000 | -- | -- | -- |
Turnover | -- | -- | -- | -- | -- | -- |
Gross Premium Income | -- | -- | -- | 44,344,000 | 41,408,000 | 41,059,000 |
Net Premium Income | -- | -- | -- | 39,065,000 | 32,917,000 | 35,578,000 |
Investment Income/(Loss) | 5,219,000 | -- | (11,726,000) | 11,624,000 | 35,400,000 | 33,593,000 |
Net Realised Gains/(Losses) on Assets | -- | -- | -- | -- | -- | -- |
Net Fair Value Gains / (Losses) on Assets | -- | -- | -- | -- | -- | -- |
Other Income/(Loss) | 6,746,000 | 9.053% | 6,186,000 | 11,132,000 | 10,591,000 | 10,399,000 |
Total Revenues | 48,739,000 | 64.431% | 29,641,000 | 61,821,000 | 78,908,000 | 79,570,000 |
Insurance Service Expenses | (19,382,000) | 0.243% | (19,335,000) | -- | -- | -- |
Net Expenses from Reinsurance Contracts | (613,000) | -1.605% | (623,000) | -- | -- | -- |
Net Finance (Expenses)/Income from Insurance Contracts | (13,894,000) | 110.006% | (6,616,000) | -- | -- | -- |
Net Finance (Expenses)/Income from Reinsurance Contracts | (734,000) | -- | 309,000 | -- | -- | -- |
Net Impairment Loss | -- | -- | -- | -- | -- | -- |
Other Expenses | (7,664,000) | 17.654% | (6,514,000) | (53,696,000) | (72,137,000) | (73,350,000) |
Other Non-operating Items | 0 | -- | 0 | 0 | 0 | 0 |
Share of results of Associates & JCEs | 0 | -- | 0 | 0 | 0 | 0 |
Profit / (Loss) before Taxation | 6,452,000 | -- | (3,138,000) | 8,125,000 | 6,771,000 | 6,220,000 |
Taxation | (845,000) | -- | 1,159,000 | (1,213,000) | (1,195,000) | (718,000) |
Profit / (Loss) for Discontinued Operations | -- | -- | -- | -- | -- | -- |
Non-controlling Interests | (144,000) | 19.008% | (121,000) | (255,000) | (250,000) | (233,000) |
Others | (360,000) | -- | 167,000 | 448,000 | 545,000 | 333,000 |
Profit/ (Loss) Attributable to Shareholders | 5,103,000 | -- | (1,933,000) | 7,105,000 | 5,871,000 | 5,602,000 |
2023/12 - Final CAD(K$) | %Chg (Compare to Final) | 2022/12 CAD(K$) | 2021/12 CAD(K$) | 2020/12 CAD(K$) | 2019/12 CAD(K$) | |
Depreciation & Amortisation | -- | -- | -- | -- | -- | -- |
Directors' Emoluments | -- | -- | -- | -- | -- | -- |
2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
EPS (cts) | 262.000 | -- | -115.000 | 355.000 | 294.000 | 277.000 |
DPS (cts) | 149.500 | -- | 135.500 | 122.000 | 112.000 | 103.000 |
Dividend Payout Ratio (%) | 57.061% | -- | -- | 34.366% | 38.095% | 37.184% |
Cash flow per share ($) | 11.136 | -- | 8.706 | 11.923 | 10.329 | 10.491 |
NBV per share ($) | 26.045 | -- | 25.136 | 30.066 | 26.973 | 25.209 |
Remarks: | Real time quote last updated: 29/11/2024 17:59 |
Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
Profit / (Loss) Attributable to Shareholders ($) | CAD 1,908,000,000 |
%Change | -21.514% |
EPS / (LPS) | CAD 0.970 |
NBV Per Share ($) | CAD 27.440 |